NCT05553093View on ClinicalTrials.gov

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

October 31, 2027

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Tirzepatide

Tirzepatide ih qw

DRUG

Insulin Glargine

6 IU ih qd

Trial Locations (1)

210006

RECRUITING

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER